Itoh H - Search Results

1

JSH Statement: Tokyo declaration promoting salt reduction by the Japanese Society of Hypertension-the JSH Tokyo declaration.

Tsuchihashi T, Ishimitsu T, Ando K, Kusaka M, Ichihara A, Miura K, Kawano Y, Ishida T, Kumagai H, Sakima A, Takase H, Hayabuchi H, Itoh H. Tsuchihashi T, et al. Among authors: itoh h. Hypertens Res. 2020 Nov;43(11):1133-1134. doi: 10.1038/s41440-020-0479-0. Epub 2020 Jun 1. Hypertens Res. 2020. PMID: 32475981 No abstract available.

2

Benefits of candesartan on arterial and renal damage of non-diabetic hypertensive patients treated with calcium channel blockers.

Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M, Itoh H. Ichihara A, et al. Among authors: itoh h. Am J Nephrol. 2006;26(5):462-8. doi: 10.1159/000096581. Epub 2006 Oct 24. Am J Nephrol. 2006. PMID: 17063001

3

Novel axonal projection from the caudal end of the ventrolateral medulla to the intermediolateral cell column.

Iigaya K, Kumagai H, Onimaru H, Kawai A, Oshima N, Onami T, Takimoto C, Kamayachi T, Hayashi K, Saruta T, Itoh H. Iigaya K, et al. Among authors: itoh h. Am J Physiol Regul Integr Comp Physiol. 2007 Feb;292(2):R927-36. doi: 10.1152/ajpregu.00254.2006. Epub 2006 Nov 2. Am J Physiol Regul Integr Comp Physiol. 2007. PMID: 17082356 Free article.

4

Role of nonproteolytically activated prorenin in pathologic, but not physiologic, retinal neovascularization.

Satofuka S, Ichihara A, Nagai N, Koto T, Shinoda H, Noda K, Ozawa Y, Inoue M, Tsubota K, Itoh H, Oike Y, Ishida S. Satofuka S, et al. Among authors: itoh h. Invest Ophthalmol Vis Sci. 2007 Jan;48(1):422-9. doi: 10.1167/iovs.06-0534. Invest Ophthalmol Vis Sci. 2007. PMID: 17197563

5

Add-on amlodipine improves arterial function and structure in hypertensive patients treated with an angiotensin receptor blocker.

Ichihara A, Kaneshiro Y, Sakoda M, Takemitsu T, Itoh H. Ichihara A, et al. Among authors: itoh h. J Cardiovasc Pharmacol. 2007 Mar;49(3):161-6. doi: 10.1097/FJC.0b013e31803104e5. J Cardiovasc Pharmacol. 2007. PMID: 17414228 Clinical Trial.

6

[Effects of ARB in metabolic syndrome].

Kumagai H, Takimoto C, Iigaya K, Kamayachi T, Saruta T, Itoh H. Kumagai H, et al. Among authors: itoh h. Nihon Rinsho. 2006 Dec 28;64 Suppl 9:599-606. Nihon Rinsho. 2006. PMID: 17458289 Review. Japanese. No abstract available.

7

Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injury.

Ishiguro K, Sasamura H, Sakamaki Y, Itoh H, Saruta T. Ishiguro K, et al. Among authors: itoh h. Hypertens Res. 2007 Jan;30(1):63-75. doi: 10.1291/hypres.30.63. Hypertens Res. 2007. PMID: 17460373

8

Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats.

Kaneshiro Y, Ichihara A, Sakoda M, Takemitsu T, Nabi AH, Uddin MN, Nakagawa T, Nishiyama A, Suzuki F, Inagami T, Itoh H. Kaneshiro Y, et al. Among authors: itoh h. J Am Soc Nephrol. 2007 Jun;18(6):1789-95. doi: 10.1681/ASN.2006091062. Epub 2007 May 9. J Am Soc Nephrol. 2007. PMID: 17494887

9

Regression of nephropathy developed in diabetes by (Pro)renin receptor blockade.

Takahashi H, Ichihara A, Kaneshiro Y, Inomata K, Sakoda M, Takemitsu T, Nishiyama A, Itoh H. Takahashi H, et al. Among authors: itoh h. J Am Soc Nephrol. 2007 Jul;18(7):2054-61. doi: 10.1681/ASN.2006080820. Epub 2007 May 30. J Am Soc Nephrol. 2007. PMID: 17538189

10

The (pro)renin receptor and the kidney.

Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M, Itoh H. Ichihara A, et al. Among authors: itoh h. Semin Nephrol. 2007 Sep;27(5):524-8. doi: 10.1016/j.semnephrol.2007.07.005. Semin Nephrol. 2007. PMID: 17868789 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,976 results

Search Page

Filters